Dachepalli Pub. (544667)

Score breakdown: P/E: 1/3 · ROCE: 1/2 · Growth: 0/2 · Dividend: 0/1

Key Financials

Strengths

• Sales growth of 43.86% shows strong top-line momentum in the latest period.
• ROCE of 17.07% indicates reasonably efficient use of capital.
• Latest quarter remains profitable: ₹1 Cr net profit on ₹15 Cr sales.
• P/E of 20.61 is not extreme if earnings stabilise; PEG of 0.47 hints at cheapness if earnings growth catches up.

Concerns

• Profit growth of -64.09% despite 43.86% sales growth signals severe margin compression.
• Piotroski F-Score of 4/9 points to weak financial health.
• Critical data missing: book value, debt/equity, promoter holding, and 52-week range; no dividend.
• Printing and publication faces structural digital disruption with no obvious competitive moat.

AI Analysis

At ₹65.49, Dachepalli Pub. presents itself as a growth story, but I prefer investments that I can understand and judge with reliable numbers. Sales grew 43.86%, which sounds attractive, yet profit fell 64.09%. That divergence is a warning sign, not a reason to celebrate. The latest quarter shows ₹15 Cr of revenue and only ₹1 Cr of net profit, a thin margin of roughly 6.7%. On a trailing P/E of 20.61, the market is paying a growth multiple for a business whose earnings are shrinking. The PEG ratio of 0.47 is misleading because it appears based on sales growth, not the actual negative profit growth. ROCE of 17.07% is decent, but with book value, debt/equity, promoter holding and even the 52-week range all missing, I cannot assess the balance-sheet risk. A Piotroski score of 4 out of 9 reinforces my concern about financial health. There is no dividend, so investors need capital gains driven by fundamental performance, and I do not see durable fundamentals. Printing and publication is a structurally challenged industry, especially for a small player with no evident moat. Any tailwind could be offset by input costs, competition, or technological change. Benjamin Graham would demand a margin of safety; at a ₹98 Cr market cap and a P/E above 20 with declining profit, there is little margin. This looks more like a speculative cyclical than a compounding investment. I would rather wait on the sidelines until margins stabilise, debt is disclosed, and earnings consistently follow sales. Until then, I pass.

Data from BSE/NSE filings. AI analysis is for educational purposes only — not investment advice. Scoring methodology · Disclaimer